{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:02:23Z","timestamp":1789628543710,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s10620-026-10126-1","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:39:13Z","timestamp":1784536753000},"page":"5654-5665","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Effects of Four Dietary Approaches on Symptom Severity and Quality of Life in Irritable Bowel Syndrome: A Randomized Controlled Trial"],"prefix":"10.1007","volume":"71","clinical-trial-number":[{"clinical-trial-number":"nct04853381","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3664-6383","authenticated-orcid":false,"given":"Nezihe","family":"Otay Lule","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5170-0523","authenticated-orcid":false,"given":"Mine","family":"Yurttagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4386-9297","authenticated-orcid":false,"given":"Abdullah Emre","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3582-9663","authenticated-orcid":false,"given":"Kemal Ozan","family":"Lule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"10126_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/01.NAJ.0000520253.57459.01","volume":"117","author":"KR Weaver","year":"2017","unstructured":"Weaver KR, Melkus GDE, Henderson WA. Irritable bowel syndrome. Am J Nurs 2017;117:48\u201355. https:\/\/doi.org\/10.1097\/01.NAJ.0000520253.57459.01.","journal-title":"Am J Nurs"},{"key":"10126_CR2","unstructured":"Akbulut G. Krause Besin ve Beslenme Bak\u0131m S\u00fcreci. 14th ed. Ankara: Nobel; 2019. p. 546\u2013549."},{"key":"10126_CR3","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3390\/nu11092162","volume":"11","author":"J Algera","year":"2019","unstructured":"Algera J, Colomier E, Simr\u00e9n M. The dietary management of patients with irritable bowel syndrome: a narrative review of the existing and emerging evidence. Nutrients 2019;11:2162. https:\/\/doi.org\/10.3390\/nu11092162.","journal-title":"Nutrients"},{"key":"10126_CR4","doi-asserted-by":"publisher","first-page":"10598","DOI":"10.3390\/ijms262110598","volume":"26","author":"I Aggeletopoulou","year":"2025","unstructured":"Aggeletopoulou I, Papantoniou K, Pastras P et al. Unraveling the Pathophysiology of Irritable Bowel Syndrome: Mechanisms and Insights. International Journal of Molecular Sciences 2025;26:10598. https:\/\/doi.org\/10.3390\/ijms262110598.","journal-title":"International Journal of Molecular Sciences"},{"key":"10126_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","volume":"17","author":"CJ Black","year":"2020","unstructured":"Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol 2020;17:473\u2013486. https:\/\/doi.org\/10.1038\/s41575-020-0286-8.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10126_CR6","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3390\/nu11071566","volume":"11","author":"D Paduano","year":"2019","unstructured":"Paduano D, Cingolani A, Tanda E, Usai P. Effects of three diets on irritable bowel syndrome and health-related quality of life. Nutrients 2019;11:1566. https:\/\/doi.org\/10.3390\/nu11071566.","journal-title":"Nutrients"},{"key":"10126_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/joim.12966","volume":"286","author":"A Rej","year":"2019","unstructured":"Rej A, Aziz I, Tornblom H, Sanders DS, Simr\u00e9n M. The role of diet in irritable bowel syndrome: implications for dietary advice. J Intern Med 2019;286:490\u2013502. https:\/\/doi.org\/10.1111\/joim.12966.","journal-title":"J Intern Med"},{"key":"10126_CR8","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5056\/jnm17116","volume":"24","author":"A Lenhart","year":"2018","unstructured":"Lenhart A, Ferch C, Shaw M, Chey WD. Use of dietary management in irritable bowel syndrome: results of a survey of over 1500 United States gastroenterologists. J Neurogastroenterol Motil 2018;24:437\u2013451. https:\/\/doi.org\/10.5056\/jnm17116.","journal-title":"J Neurogastroenterol Motil"},{"key":"10126_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.15403\/jgld.2014.1121.273.avy","volume":"27","author":"A Rej","year":"2018","unstructured":"Rej A, Avery A, Ford AC et al. Clinical application of dietary therapies in irritable bowel syndrome. J Gastrointest Liver Dis 2018;27:307\u2013316. https:\/\/doi.org\/10.15403\/jgld.2014.1121.273.avy.","journal-title":"J Gastrointest Liver Dis"},{"key":"10126_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.foodres.2017.04.001","volume":"110","author":"E Zannini","year":"2018","unstructured":"Zannini E, Arendt EK. Low FODMAPs and gluten-free foods for irritable bowel syndrome treatment: lights and shadows. Food Res Int 2018;110:33\u201341. https:\/\/doi.org\/10.1016\/j.foodres.2017.04.001.","journal-title":"Food Res Int"},{"key":"10126_CR11","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3390\/nu10121873","volume":"10","author":"M Calasso","year":"2018","unstructured":"Calasso M, Francavilla R, Cristofori F, De Angelis M, Gobbetti M. New protocol for production of reduced-gluten wheat bread and pasta and clinical effect in patients with irritable bowel syndrome: a randomised, double-blind, cross-over study. Nutrients 2018;10:1873. https:\/\/doi.org\/10.3390\/nu10121873.","journal-title":"Nutrients"},{"key":"10126_CR12","unstructured":"Turk OP. Adaptation and validation of a food frequency questionnaire including FODMAP intake for the Turkish population. PhD thesis. Hacettepe University; 2017."},{"key":"10126_CR13","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","volume":"11","author":"CY Francis","year":"1997","unstructured":"Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997;11:395\u2013402. https:\/\/doi.org\/10.1046\/j.1365-2036.1997.142318000.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"10126_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","volume":"116","author":"BE Lacy","year":"2021","unstructured":"Lacy BE, Pimentel M, Brenner DM et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol 2021;116:17\u201344. https:\/\/doi.org\/10.14309\/ajg.0000000000001036.","journal-title":"Am J Gastroenterol"},{"key":"10126_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1023\/A:1018831127942","volume":"43","author":"DL Patrick","year":"1998","unstructured":"Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci 1998;43:400\u2013411. https:\/\/doi.org\/10.1023\/A:1018831127942.","journal-title":"Dig Dis Sci"},{"key":"10126_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2475-3181.1000137","volume":"2","author":"U Bno","year":"2016","unstructured":"Bno U. Psychometric properties of the irritable bowel syndrome quality of life scale in Turkey. J Hepatol Gastrointest Disord 2016;2:1\u20137. https:\/\/doi.org\/10.4172\/2475-3181.1000137.","journal-title":"J Hepatol Gastrointest Disord"},{"key":"10126_CR17","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.pop.2017.07.009","volume":"44","author":"DN Defrees","year":"2017","unstructured":"Defrees DN, Bailey J. Irritable bowel syndrome: epidemiology, pathophysiology, diagnosis, and treatment. Prim Care 2017;44:655\u2013671. https:\/\/doi.org\/10.1016\/j.pop.2017.07.009.","journal-title":"Prim Care"},{"key":"10126_CR18","doi-asserted-by":"publisher","first-page":"544","DOI":"10.5056\/jnm18082","volume":"24","author":"YS Kim","year":"2018","unstructured":"Kim YS, Kim N. Sex-gender differences in irritable bowel syndrome. J Neurogastroenterol Motil 2018;24:544\u2013558. https:\/\/doi.org\/10.5056\/jnm18082.","journal-title":"J Neurogastroenterol Motil"},{"key":"10126_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.47176\/mjiri.34.72","volume":"34","author":"K Mahmood","year":"2020","unstructured":"Mahmood K, Riaz R, Salman Ul Haq M, Hamid K, Jawed H. Association of cigarette smoking with irritable bowel syndrome: a cross-sectional study. Med J Islam Repub Iran 2020;34:72. https:\/\/doi.org\/10.47176\/mjiri.34.72.","journal-title":"Med J Islam Repub Iran"},{"key":"10126_CR20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/15504263.2017.1322226","volume":"13","author":"L Sirri","year":"2017","unstructured":"Sirri L, Grandi S, Tossani E. Smoking in irritable bowel syndrome: a systematic review. J Dual Diagn 2017;13:184\u2013200. https:\/\/doi.org\/10.1080\/15504263.2017.1322226.","journal-title":"J Dual Diagn"},{"key":"10126_CR21","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.3748\/wjg.v23.i21.3771","volume":"23","author":"A Cozma-Petrut","year":"2017","unstructured":"Cozma-Petrut A, Loghin F, Miere D, Dumitrascu DL. Diet in irritable bowel syndrome: what to recommend, not what to forbid to patients. World J Gastroenterol 2017;23:3771\u20133783. https:\/\/doi.org\/10.3748\/wjg.v23.i21.3771.","journal-title":"World J Gastroenterol"},{"key":"10126_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5507\/bp.2017.057","volume":"162","author":"B Radovanovic-Dinic","year":"2018","unstructured":"Radovanovic-Dinic B, Tesic-Rajkovic S, Grgov S, Petrovic G, Zivkovic V. Irritable bowel syndrome\u2014from etiopathogenesis to therapy. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2018;162:1\u20139. https:\/\/doi.org\/10.5507\/bp.2017.057.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10126_CR23","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3390\/jcm14051708","volume":"14","author":"JS Severo","year":"2025","unstructured":"Severo JS, Silva ACA, Santos BLB et al. Physical exercise as a therapeutic approach in gastrointestinal diseases. Journal of Clinical Medicine 2025;14:1708. https:\/\/doi.org\/10.3390\/jcm14051708.","journal-title":"Journal of Clinical Medicine"},{"key":"10126_CR24","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.3390\/jcm12165359","volume":"12","author":"G Riezzo","year":"2023","unstructured":"Riezzo G, Prospero L, D\u2019Attoma B et al. The impact of a twelve-week moderate aerobic exercise program on gastrointestinal symptom profile and psychological well-being of irritable bowel syndrome patients: preliminary data from a Southern Italy cohort. J Clin Med 2023;12:5359. https:\/\/doi.org\/10.3390\/jcm12165359.","journal-title":"J Clin Med"},{"key":"10126_CR25","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3390\/nu16162657","volume":"16","author":"C Li","year":"2024","unstructured":"Li C, Li J, Zhou Q et al. Effects of physical exercise on the microbiota in irritable bowel syndrome. Nutrients 2024;16:2657. https:\/\/doi.org\/10.3390\/nu16162657.","journal-title":"Nutrients"},{"key":"10126_CR26","doi-asserted-by":"publisher","first-page":"4009","DOI":"10.3748\/wjg.v22.i15.4009","volume":"22","author":"L Maagaard","year":"2016","unstructured":"Maagaard L, Ankersen DV, Vegh Z et al. Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World J Gastroenterol 2016;22:4009\u20134019. https:\/\/doi.org\/10.3748\/wjg.v22.i15.4009.","journal-title":"World J Gastroenterol"},{"key":"10126_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/apt.13706","volume":"44","author":"SL Peters","year":"2016","unstructured":"Peters SL, Yao CK, Philpott H, Yelland GW, Muir JG, Gibson PR. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:447\u2013459. https:\/\/doi.org\/10.1111\/apt.13706.","journal-title":"Aliment Pharmacol Ther"},{"key":"10126_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-021-01868-5","volume":"21","author":"K Naseri","year":"2021","unstructured":"Naseri K, Dabiri H, Rostami-Nejad M et al. Influence of low FODMAP\u2013gluten free diet on gut microbiota alterations and symptom severity in Iranian patients with irritable bowel syndrome. BMC Gastroenterol 2021;21:1\u201314. https:\/\/doi.org\/10.1186\/s12876-021-01868-5.","journal-title":"BMC Gastroenterol"},{"key":"10126_CR29","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.cgh.2015.12.031","volume":"14","author":"I Aziz","year":"2016","unstructured":"Aziz I, Trott N, Briggs R, North JR, Hadjivassiliou M, Sanders DS. Efficacy of a gluten-free diet in subjects with irritable bowel syndrome-diarrhea unaware of their HLA-DQ2\/8 genotype. Clin Gastroenterol Hepatol 2016;14:696\u2013703. https:\/\/doi.org\/10.1016\/j.cgh.2015.12.031.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10126_CR30","unstructured":"Erdin\u00e7 A\u015e. Effects of different dietary approaches on symptomatic treatment in individuals with constipation-predominant irritable bowel syndrome. PhD thesis. Hacettepe University; 2018."},{"key":"10126_CR31","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.3390\/jcm13247531","volume":"13","author":"H Haghbin","year":"2024","unstructured":"Haghbin H, Hasan F, Gangwani MK et al. Efficacy of dietary interventions for irritable bowel syndrome: a systematic review and network meta-analysis. J Clin Med 2024;13:7531. https:\/\/doi.org\/10.3390\/jcm13247531.","journal-title":"J Clin Med"},{"key":"10126_CR32","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/s41395-018-0195-4","volume":"113","author":"J Dionne","year":"2018","unstructured":"Dionne J, Ford AC, Yuan Y et al. A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of irritable bowel syndrome. Am J Gastroenterol 2018;113:1290\u20131300. https:\/\/doi.org\/10.1038\/s41395-018-0195-4.","journal-title":"Am J Gastroenterol"},{"key":"10126_CR33","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1136\/gutjnl-2021-325214","volume":"71","author":"CJ Black","year":"2022","unstructured":"Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut 2022;71:1117\u20131126. https:\/\/doi.org\/10.1136\/gutjnl-2021-325214.","journal-title":"Gut"},{"key":"10126_CR34","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1111\/jgh.14051","volume":"33","author":"MJ Zahedi","year":"2018","unstructured":"Zahedi MJ, Behrouz V, Azimi M. Low fermentable oligo-di-mono-saccharides and polyols diet versus general dietary advice in patients with diarrhea-predominant irritable bowel syndrome: a randomized controlled trial. J Gastroenterol Hepatol 2018;33:1192\u20131199. https:\/\/doi.org\/10.1111\/jgh.14051.","journal-title":"J Gastroenterol Hepatol"},{"key":"10126_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325214","author":"CJ Black","year":"2021","unstructured":"Black CJ, Staudacher HM, Ford AC. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2021. https:\/\/doi.org\/10.1136\/gutjnl-2021-325214.","journal-title":"Gut"},{"key":"10126_CR36","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1007\/s10620-025-09241-2","volume":"70","author":"R Khurana","year":"2025","unstructured":"Khurana R, Rakhra G. Assessing the impact of the low-FODMAP diet on IBS management in Asian countries: a systematic review and meta-analysis of evidence. Dig Dis Sci 2025;70:4060\u20134073. https:\/\/doi.org\/10.1007\/s10620-025-09241-2.","journal-title":"Dig Dis Sci"},{"key":"10126_CR37","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3390\/nu9090940","volume":"9","author":"E Altobelli","year":"2017","unstructured":"Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP diet improves irritable bowel syndrome symptoms: a meta-analysis. Nutrients 2017;9:940. https:\/\/doi.org\/10.3390\/nu9090940.","journal-title":"Nutrients"},{"key":"10126_CR38","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.3390\/nu13072460","volume":"13","author":"J Hahn","year":"2021","unstructured":"Hahn J, Choi J, Chang MJ. Effect of low FODMAPs diet on irritable bowel syndromes: a systematic review and meta-analysis of clinical trials. Nutrients 2021;13:2460. https:\/\/doi.org\/10.3390\/nu13072460.","journal-title":"Nutrients"},{"key":"10126_CR39","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1007\/s00394-020-02473-0","volume":"60","author":"AS van Lanen","year":"2021","unstructured":"van Lanen AS, de Bree A, Greyling A. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis. Eur J Nutr 2021;60:3505\u20133522. https:\/\/doi.org\/10.1007\/s00394-020-02473-0.","journal-title":"Eur J Nutr"},{"key":"10126_CR40","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3389\/fpsyt.2020.00865","volume":"11","author":"LP Manning","year":"2020","unstructured":"Manning LP, Yao CK, Biesiekierski JR. Therapy of IBS: is a low FODMAP diet the answer? Front Psychiatry 2020;11:865. https:\/\/doi.org\/10.3389\/fpsyt.2020.00865.","journal-title":"Front Psychiatry"},{"key":"10126_CR41","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1016\/j.cgh.2022.02.045","volume":"20","author":"A Rej","year":"2022","unstructured":"Rej A, Sanders DS, Shaw CC et al. Efficacy and acceptability of dietary therapies in non-constipated irritable bowel syndrome: a randomized trial of traditional dietary advice, the low FODMAP diet, and the gluten-free diet. Clin Gastroenterol Hepatol 2022;20:2876-2887.e15. https:\/\/doi.org\/10.1016\/j.cgh.2022.02.045.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10126_CR42","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1016\/j.cgh.2020.08.040","volume":"19","author":"MI Pinto-Sanchez","year":"2021","unstructured":"Pinto-Sanchez MI, Nardelli A, Borojevic R et al. Gluten-Free Diet Reduces Symptoms, Particularly Diarrhea, in Patients With Irritable Bowel Syndrome and Antigliadin IgG. Clin Gastroenterol Hepatol 2021;19:2343-2352.e8. https:\/\/doi.org\/10.1016\/j.cgh.2020.08.040.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10126_CR43","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/S2468-1253(25)00090-1","volume":"10","author":"CL Seiler","year":"2025","unstructured":"Seiler CL, Rueda GH, Miranda PM et al. Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial. Lancet Gastroenterol Hepatol 2025;10:794\u2013805. https:\/\/doi.org\/10.1016\/S2468-1253(25)00090-1.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10126_CR44","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1055\/a-0828-5052","volume":"57","author":"A Madisch","year":"2019","unstructured":"Madisch A. Gluten-free diet and low FODMAP diet: no or minor evidence for treating irritable bowel syndrome. Z Gastroenterol 2019;57:518\u2013519. https:\/\/doi.org\/10.1055\/a-0828-5052.","journal-title":"Z Gastroenterol"},{"key":"10126_CR45","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1053\/j.gastro.2015.07.054","volume":"149","author":"L B\u00f6hn","year":"2015","unstructured":"B\u00f6hn L, St\u00f6rsrud S, Liljebo T et al. Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial. Gastroenterology 2015;149:1399\u2013407.e2. https:\/\/doi.org\/10.1053\/j.gastro.2015.07.054.","journal-title":"Gastroenterology"},{"key":"10126_CR46","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1038\/ajg.2016.434","volume":"111","author":"SL Eswaran","year":"2016","unstructured":"Eswaran SL, Chey WD, Han-Markey T, Ball S, Jackson K. A randomized controlled trial comparing the low FODMAP diet vs modified NICE guidelines in US adults with IBS-D. Am J Gastroenterol 2016;111:1824\u20131832. https:\/\/doi.org\/10.1038\/ajg.2016.434.","journal-title":"Am J Gastroenterol"},{"key":"10126_CR47","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1016\/j.cgh.2017.06.044","volume":"15","author":"S Eswaran","year":"2017","unstructured":"Eswaran S, Chey WD, Jackson K, Pillai S, Chey SW, Han-Markey T. A diet low in fermentable oligo-, di-, and monosaccharides and polyols improves quality of life and reduces activity impairment in patients with irritable bowel syndrome and diarrhea. Clin Gastroenterol Hepatol 2017;15:1890\u20139.e3. https:\/\/doi.org\/10.1016\/j.cgh.2017.06.044.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10126_CR48","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/ncp.10233","volume":"34","author":"TL Kortlever","year":"2019","unstructured":"Kortlever TL, Ten Bokkel Huinink S, Offereins M et al. Low-FODMAP diet is associated with improved quality of life in IBS patients: a prospective observational study. Nutr Clin Pract 2019;34:623\u2013630. https:\/\/doi.org\/10.1002\/ncp.10233.","journal-title":"Nutr Clin Pract"},{"key":"10126_CR49","doi-asserted-by":"publisher","first-page":"683191","DOI":"10.3389\/fnut.2021.683191","volume":"8","author":"J Wang","year":"2021","unstructured":"Wang J, Yang P, Zhang L, Hou X. A low-FODMAP diet improves the global symptoms and bowel habits of adult IBS patients: a systematic review and meta-analysis. Front Nutr 2021;8:683191. https:\/\/doi.org\/10.3389\/fnut.2021.683191.","journal-title":"Front Nutr"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10126-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10126-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10126-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:07:54Z","timestamp":1789625274000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10126-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10126"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10126-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the ethical principles of the Declaration of Helsinki. Ethical approval was obtained from the Gaziantep University Clinical Research Ethics Committee, and the trial was registered at ClinicalTrials.gov (NCT04853381; first posted on 21 April 2021). Written informed consent was obtained from all participants prior to study enrollment. The study was reported in accordance with the CONSORT guidelines for randomized controlled trials.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}]}}